Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingJun 7, 2023Lidocaine 2.5% & Prilocaine 2.5% CreamCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0821-2023Class IIOngoingJun 7, 2023Levofloxacin Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0820-2023Class IIOngoingJun 7, 2023Levofloxacin Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0819-2023Class IIOngoingJun 7, 2023Levofloxacin Injection 500mg/20 mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0818-2023Class IIOngoingJun 7, 2023Levocarnitine Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0817-2023Class IIOngoingJun 7, 2023Levetiracetam Oral Solution 100 mg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0816-2023Class IIOngoingJun 7, 2023Lactulose SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0815-2023Class IIOngoingJun 7, 2023Lactulose SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0814-2023Class IIOngoingJun 7, 2023Ketorolac Tromethamine Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0813-2023Class IIOngoingJun 7, 2023IC-GreenCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0812-2023Class IIOngoingJun 7, 2023Hydromorphone Hydrochloride InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0811-2023Class IIOngoingJun 7, 2023Hydrocortisone and Acetic Acid Otic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0810-2023Class IIOngoingJun 7, 2023HydrALAZINE HCl InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0809-2023Class IIOngoingJun 7, 2023Guaifenesin Oral SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0808-2023Class IIOngoingJun 7, 2023Guaiatussin AC Sugar-FreeCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0807-2023Class IIOngoingJun 7, 2023Granisetron HCl InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0806-2023Class IIOngoingJun 7, 2023Gonak Hypromellose Ophthalmic Solution 25mg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0805-2023Class IIOngoingJun 7, 2023Fluticasone Propionate Nasal SprayCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0804-2023Class IIOngoingJun 7, 2023Ferrous Sulfate Iron Supplement DropsCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0803-2023Class IIOngoingJun 7, 2023Ephedrine Sulfate InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0802-2023Class IIOngoingJun 7, 2023DOCU LIQUIDCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0801-2023Class IIOngoingJun 7, 2023Diuril (chlorothiazide sodium) InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0800-2023Class IIOngoingJun 7, 2023Dicyclomine Hydrochloride Injection USPCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0799-2023Class IIOngoingJun 7, 2023DetomiSedCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0798-2023Class IIOngoingJun 7, 2023Cromolyn Sodium Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0797-2023Class IIOngoingJun 7, 2023Clobetasol Propionate ShampooCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0796-2023Class IIOngoingJun 7, 2023Clobetasol Propionate OintmentCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0795-2023Class IIOngoingJun 7, 2023Clobetasol Propionate CreamCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0794-2023Class IIOngoingJun 7, 2023Cimetidine HCl Oral Solution 300mg/5mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0793-2023Class IIOngoingJun 7, 2023Ciclopirox Topical Solution 8%CGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0792-2023Class IIOngoingJun 7, 2023Cetrorelix Acetate for InjectionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0791-2023Class IIOngoingJun 7, 2023Calcitriol Injection 1 mcg/mLCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0790-2023Class IIOngoingJun 7, 2023Calcipotriene Topical SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0789-2023Class IIOngoingJun 7, 2023AK-POLY-BACCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0788-2023Class IIOngoingJun 7, 2023Azelastine Hydrochloride Nasal SprayCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0787-2023Class IIOngoingJun 7, 2023Artificial Tears OintmentCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0786-2023Class IIOngoingJun 7, 2023Artificial Tears SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0785-2023Class IIOngoingJun 7, 2023Apraclonidine Ophthalmic Solution 0.5%CGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0784-2023Class IIOngoingJun 7, 2023Albuterol Sulfate SyrupCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0783-2023Class IIOngoingJun 7, 2023Acyclovir Oral SuspensionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0782-2023